Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Saban Capital Acquisition Corp. (SCAC): Billionaire Glenn Russell Dubin’s Highbridge Capital Management Acquires 7.45% Stake

Page 1 of 8

Billionaire Glenn Russell Dubin‘s Highbridge Capital Management decided to be among the first investors in Saban Capital Acquisition Corp. (NASDAQ:SCAC), a “blank check” company that just recently went public. As per a new 13G filing filed on September 26, Highbridge Capital Management purchased 1.75 million Class A Shares, which account for 7.45% of the float. Another investor that has just reported a 6.4% stake in Saban Capital Acquisition Corp is billionaire Louis Bacon‘s Moore Global Investments (see article).


Follow Saban Capital Acquisition Corp.
Trade (SCAC) Now!

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Highbridge Capital Management 0 1,750,000 0 1,750,000 1,750,000 7.45%
Highbridge International 0 1,750,000 0 1,750,000 1,750,000 7.45%

Glenn Russell Dubin
Glenn Russell Dubin
Highbridge Capital Management

Page 1 of 8 – SEC Filing

Washington, D.C. 20549
Under the Securities Exchange Act of 1934
(Amendment No.   )*

Saban Capital
Acquisition Corp.

(Name of Issuer)

Class A Ordinary
Shares, par value $0.0001 per share

(Title of Class of Securities)


(CUSIP Number)

16, 2016

(Date of event which requires filing of this statement)
Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed:
¨ Rule 13d-1(b)
x Rule 13d-1(c)
¨ Rule 13d-1(d)
(Page 1 of 8 Pages)


*The remainder of this cover page shall
be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

** The Class A Ordinary have no CUSIP
number. The CUSIP number for the units which include Class A Ordinary is 78516C205.

The information required in the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all
other provisions of the Act (however, see the Notes)

Follow Saban Capital Acquisition Corp.
Trade (SCAC) Now!
Page 1 of 8

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!